onr:"swepub:oai:gup.ub.gu.se/35601"
Sökning: onr:"swepub:oai:gup.ub.gu.se/35601" > Can treatment with ...
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
- Ekman, Inger,1952Gothenburg University,Göteborgs universitet,Institutionen för omvårdnad,Institute of Nursing (författare)
Can treatment with ACE-inhibitors in elderly patients with moderate to severe heart failure be improved by a nurse-monitored structured care program?
- Artikel/kapitelEngelska2003
Förlag, utgivningsår, omfång ...
- 2003
Nummerbeteckningar
- LIBRIS-ID:oai:gup.ub.gu.se/35601
- https://gup.ub.gu.se/publication/35601URI
Kompletterande språkuppgifter
- Språk:engelska
Ingår i deldatabas
- SwePubSwePub
Klassifikation
Anmärkningar
- Can treatment with angiotensin-converting enzyme inhibitors in elderly patients with moderate to severe chronic heart failure be improved by a nurse-monitored structured care program? A randomized controlled trial. OBJECTIVE: The purpose of this study was to examine whether a nurse-monitored structured care program resulted in a more effective use of angiotensin-converting enzyme (ACE) inhibitors in elderly patients compared with standard care in patients with chronic heart failure (CHF). METHODS: Hospitalized patients were screened to identify individuals with CHF, age more than 65 years, New York Heart Association classification III to IV, and no contraindications to ACE inhibitor treatment. One hundred forty-five patients were randomized to a nurse-monitored structured care program that included uptitration of enalapril to a target dose of 10 mg twice a day or to standard care. Six-month follow-up data were collected. RESULTS: The mean age of the randomized patients was 81 years. Although the proportion of patients treated with an ACE inhibitor did not differ between structured care (70%) and standard care (64%), the number of patients with the target ACE inhibitor dose was significantly higher in the structured care group (26% versus 11% in the standard care group; P <.018). Treatment had to be discontinued in 26% of the patients because of adverse effects. CONCLUSION: The patients in this study were older than in previous intervention studies and had considerable comorbidity and reduced tolerance for ACE inhibitors. ACE inhibitor treatment was underused but improved with the structured care program, although achieved treatment levels were below those in the large intervention trials in patients with CHF.
Biuppslag (personer, institutioner, konferenser, titlar ...)
- Andersson, Björn (författare)
- Ehnfors, M (författare)
- Matejka, Göran (författare)
- Persson, Bengt (författare)
- Fagerberg, Björn,1943Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin, Avdelningen för internmedicin,Wallenberglaboratoriet,Institute of Internal Medicine, Dept of Medicine,Wallenberg Laboratory(Swepub:gu)xfagbj (författare)
- Göteborgs universitetInstitutionen för omvårdnad (creator_code:org_t)
Sammanhörande titlar
- Ingår i:Heart & Lung32:1, s. 3-90147-9563
Internetlänk
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
Hitta mer i SwePub
- Av författaren/redakt...
- Ekman, Inger, 19 ...
- Andersson, Björn
- Ehnfors, M
- Matejka, Göran
- Persson, Bengt
- Fagerberg, Björn ...
- Artiklar i publikationen
- Heart & Lung
- Av lärosätet
- Göteborgs universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
